Cargando…

Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia

One case of acute panmyelosis with myelofibrosis (APMF) is here reported. A 45 year old male presented with abrupt onset of rapidly progressing low backache, weakness and pancytopenia. On examination there was no organomegaly. Peripheral blood examination revealed normocytic normochromic red blood c...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Tathagata, Gupta, Srishti, Sharma, Ajay, Sharma, Sanjeevan, Gupta, Devika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684347/
https://www.ncbi.nlm.nih.gov/pubmed/23795280
http://dx.doi.org/10.4084/MJHID.2013.042
_version_ 1782273552488071168
author Chatterjee, Tathagata
Gupta, Srishti
Sharma, Ajay
Sharma, Sanjeevan
Gupta, Devika
author_facet Chatterjee, Tathagata
Gupta, Srishti
Sharma, Ajay
Sharma, Sanjeevan
Gupta, Devika
author_sort Chatterjee, Tathagata
collection PubMed
description One case of acute panmyelosis with myelofibrosis (APMF) is here reported. A 45 year old male presented with abrupt onset of rapidly progressing low backache, weakness and pancytopenia. On examination there was no organomegaly. Peripheral blood examination revealed normocytic normochromic red blood cells with 10% circulating blasts. Flowcytometric examination of peripheral blood revealed blasts which were positive for CD34, HLA− DR and myeloid associated antigens (i.e. CD13 and CD33). Blasts were negative for anti MPO. Bone marrow aspirate resulted in a dry tap. Bone marrow biopsy revealed panmyeloid proliferation with scattered blasts which were CD34 positive on imunohistochemistry and negative for anti MPO. Reticulin stain showed grade III myelofibrosis (WHO). Differential diagnosis considered included AML-M7, MDS-RAEB II and AML with myelodysplasia. He was started on chemotherapy [idarubicin and cytarabine; 3+7 induction regimen followed by three cycles of HIDAC (High dose cytosine arabinoside)] after which patient was in complete morphological remission with markedly reduced bone marrow fibrosis. He is now being worked up for allogeneic stem cell transplantation. Patient is asymptomatic at eight months of diagnosis. In conclusion these patients should be managed aggressively with AML therapy and this case report reaffirms the fact that APMF is subtype of AML.
format Online
Article
Text
id pubmed-3684347
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-36843472013-06-21 Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia Chatterjee, Tathagata Gupta, Srishti Sharma, Ajay Sharma, Sanjeevan Gupta, Devika Mediterr J Hematol Infect Dis Case Report One case of acute panmyelosis with myelofibrosis (APMF) is here reported. A 45 year old male presented with abrupt onset of rapidly progressing low backache, weakness and pancytopenia. On examination there was no organomegaly. Peripheral blood examination revealed normocytic normochromic red blood cells with 10% circulating blasts. Flowcytometric examination of peripheral blood revealed blasts which were positive for CD34, HLA− DR and myeloid associated antigens (i.e. CD13 and CD33). Blasts were negative for anti MPO. Bone marrow aspirate resulted in a dry tap. Bone marrow biopsy revealed panmyeloid proliferation with scattered blasts which were CD34 positive on imunohistochemistry and negative for anti MPO. Reticulin stain showed grade III myelofibrosis (WHO). Differential diagnosis considered included AML-M7, MDS-RAEB II and AML with myelodysplasia. He was started on chemotherapy [idarubicin and cytarabine; 3+7 induction regimen followed by three cycles of HIDAC (High dose cytosine arabinoside)] after which patient was in complete morphological remission with markedly reduced bone marrow fibrosis. He is now being worked up for allogeneic stem cell transplantation. Patient is asymptomatic at eight months of diagnosis. In conclusion these patients should be managed aggressively with AML therapy and this case report reaffirms the fact that APMF is subtype of AML. Università Cattolica del Sacro Cuore 2013-06-04 /pmc/articles/PMC3684347/ /pubmed/23795280 http://dx.doi.org/10.4084/MJHID.2013.042 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Chatterjee, Tathagata
Gupta, Srishti
Sharma, Ajay
Sharma, Sanjeevan
Gupta, Devika
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
title Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
title_full Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
title_fullStr Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
title_full_unstemmed Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
title_short Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
title_sort acute panmyelosis with myelofibrosis - a rare subtype of acute myeloid leukemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684347/
https://www.ncbi.nlm.nih.gov/pubmed/23795280
http://dx.doi.org/10.4084/MJHID.2013.042
work_keys_str_mv AT chatterjeetathagata acutepanmyelosiswithmyelofibrosisararesubtypeofacutemyeloidleukemia
AT guptasrishti acutepanmyelosiswithmyelofibrosisararesubtypeofacutemyeloidleukemia
AT sharmaajay acutepanmyelosiswithmyelofibrosisararesubtypeofacutemyeloidleukemia
AT sharmasanjeevan acutepanmyelosiswithmyelofibrosisararesubtypeofacutemyeloidleukemia
AT guptadevika acutepanmyelosiswithmyelofibrosisararesubtypeofacutemyeloidleukemia